1995
DOI: 10.1016/0278-6915(94)00128-b
|View full text |Cite
|
Sign up to set email alerts
|

Pathology considerations for, and subsequent risk assessment of, chemicals identified as immunosuppressive in routine toxicology

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
20
0

Year Published

2000
2000
2018
2018

Publication Types

Select...
3
3
2

Relationship

0
8

Authors

Journals

citations
Cited by 38 publications
(20 citation statements)
references
References 13 publications
0
20
0
Order By: Relevance
“…Nevertheless, we cannot point out a potentially causal relationship for the augmented kidney weight in treated animals. Yet our ndings showed neither histopathological alterations nor differences in renal function evaluated by relevant pathophysiological markers, as urea and creatinine plasma concentration (Basketter et al 1995). Furthermore, there is no evidence of sevourane-nephrotoxic effects in mouse or rat models (Frink et al 1992, Malan et al 1993.…”
Section: Discussionmentioning
confidence: 98%
“…Nevertheless, we cannot point out a potentially causal relationship for the augmented kidney weight in treated animals. Yet our ndings showed neither histopathological alterations nor differences in renal function evaluated by relevant pathophysiological markers, as urea and creatinine plasma concentration (Basketter et al 1995). Furthermore, there is no evidence of sevourane-nephrotoxic effects in mouse or rat models (Frink et al 1992, Malan et al 1993.…”
Section: Discussionmentioning
confidence: 98%
“…Thus, the following standard clinical and anatomic pathology markers will be included in the 28-day rat study and 90-day dog study specifications: serum biochemical markers such as globulin levels, hematology (including differential), gross pathology findings, immune system-related organ weights, and histologic examination of immune system-related tissues (Basketter et al, 1995).…”
Section: Immunotoxicitymentioning
confidence: 99%
“…In addition, the lymphoid tissue that drains or contacts the site of chemical administration (and therefore is likely to be exposed to the highest concentration of the material) should be specifically examined (Basketter et al, 1995). These sites include the gutassociated lymphoid tissues (GALT) for orally administered materials, bronchus-associated lymphoid tissues (BALT), and nasal-associated lymphoid tissues (NALT) for materials administered by the inhalation route, and the regional draining lymph nodes for chemicals administered by the dermal route.…”
Section: Immunotoxicitymentioning
confidence: 99%
“…Altered thymic morphology and function have been associated with immunotoxicity caused by a variety of agents and changes in thymus architecture, (17,18). In addition to the thymus, a thorough evaluation of lymphoid tissues should include examination of the spleen, lymph nodes local and distal to the site of exposure, the bone marrow, and hematology (1).…”
Section: Lymphoid Tissuementioning
confidence: 99%
“…Although it is probably the case that the application of more sophisticated (enhanced) immunopathology would increase the sensitivity of histopathological approaches, there is some debate about whether, in isolation, standard examinations of the weight, architecture and cellularity of lymphoid tissues are of suf cient sensitivity to serve alone as a rst tier of immunotoxicity testing (1,8,20). For this reason there has been considerable interest in the application of immune function tests and related approaches.…”
Section: Lymphoid Tissuementioning
confidence: 99%